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Abstract	  
	  
This	   thesis	  aimed	  to	  define	   the	   role	  of	   reactive	  oxygen	  species	   (ROS),	  produced	  by	  
the	  NADPH	  oxidase	  of	  myeloid	  cells,	   in	   the	   regulation	  of	   lymphocyte	   function	  with	  
focus	  on	  ROS-­‐induced	  dysfunction	  of	  natural	   killer	   (NK)	   cells	   and	  T	   lymphocytes	   in	  
myeloid	  leukemia.	  In	  Paper	   I,	  a	  novel	  mechanism	  is	  presented	  by	  which	  specifically	  
activated	   T	   lymphocytes	   evade	   inactivation	   by	   ROS	   after	   antigen	   presentation.	  
Antigen-­‐presenting	   dendritic	   cells	  were	   found	   to	   induce	   ROS-­‐neutralizing	   thiols	   on	  
the	   surface	   of	   antigen-­‐specific	   T	   cells,	   but	   not	   on	   T	   cells	   that	   lacked	   antigen	  
specificity.	   These	   findings	   may	   explain	   why	   antigen-­‐specific	   T	   cells	   remain	   viable	  
under	   conditions	  of	   oxidative	   stress.	  Paper	   II	   shows	   that	   subsets	   of	   leukemic	   cells	  
recovered	   from	   patients	   with	   acute	  myeloid	   leukemia	   (AML)	   produce	   and	   release	  
ROS	  via	  a	  membrane-­‐bound	  NADPH	  oxidase,	  and	  that	  ROS-­‐producing	  leukemic	  cells	  
initiate	   a	  PARP-­‐1-­‐dependent	  pathway	  of	   cell	   death	   (parthanatos)	   in	  NK	   cells	   and	  T	  
cells.	  The	  results	  presented	  in	  Paper	  III	  demonstrate	  that	  treatment	  of	  AML	  patients	  
with	   a	   NADPH	   oxidase	   inhibitor	   (histamine	   dihydrochloride)	   was	   preferentially	  
efficacious	  among	  patients	  with	  monocytic	   leukemias	   (FAB	  classes	  M4	  and	  M5),	   in	  
which	   cells	   of	   the	   leukemic	   clone	   expressed	   a	   ROS-­‐producing	  NADPH	   oxidase	   and	  
functional	   histamine	   H2	   receptors.	   The	   results	   presented	   in	   Paper	   IV	   imply	   that	  
malignant	   cells	   recovered	   from	   patients	  with	   chronic	  myeloid	   leukemia	   utilize	   the	  
ROS/PARP-­‐1	  axis	  to	  induce	  NK	  cell	  parthanatos	  and	  that	  PARP-­‐1	  inhibition	  maintains	  
functions	  of	  T	  cells	  and	  NK	  cells	  under	  conditions	  of	  oxidative	  stress.	  Paper	  V	  aimed	  
to	  define	  the	  intracellular	  pathways	  of	  ROS-­‐induced	  PARP-­‐1	  activation	  with	  ensuing	  
cell	   death	   in	   lymphocytes.	   The	   results	   suggest	   that	   the	  mitogen-­‐activated	   protein	  
kinase	   ERK1/2	   is	   involved	   in	   ROS-­‐induced	   signal	   transduction	   and	   that	   ERK1/2	   is	  
activated	  upstream	  of	  PARP-­‐1	  in	  ROS-­‐dependent	  lymphocyte	  parthanatos.	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